...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.
【24h】

Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.

机译:聚乙二醇修饰的腺苷脱氨酶可改善部分腺苷脱氨酶缺乏症的肺部疾病,但不能改善肝脏疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

Adenosine deaminase (ADA) is expressed in all tissues in varying levels and controlled in a cell-specific, developmentally programmed fashion. The highest level of ADA is expressed in the thymus, followed by peripheral lymphoid tissues and'the gastrointestinal tract.Complete ADA deficiency, inherited as an autosomal recessive trait, causes a systemic metabolic disorder and severe combined immunodeficiency. The immunodeficiency is thought to be secondary to the accumulation of purine metabolites, which are cytotoxic to immature lymphocytes. The typical manifestation of ADA deficiency is profound T-cell, B-cell, and natural killer cell lymphopenia, resulting in failure to thrive and recurrent or persistent infections, which can be fatal.
机译:腺苷脱氨酶(ADA)在所有组织中均以不同水平表达,并以细胞特异性,发育程序化的方式进行控制。最高水平的ADA在胸腺中表达,其次是外周淋巴组织和胃肠道。完全的ADA缺乏症(作为常染色体隐性遗传)遗传导致系统性代谢紊乱和严重的联合免疫缺陷。免疫缺陷被认为是嘌呤代谢产物积累的继发性产物,嘌呤代谢产物对未成熟的淋巴细胞具有细胞毒性。 ADA缺乏症的典型表现是深层T细胞,B细胞和自然杀伤细胞淋巴细胞减少,导致无法failure壮成长,反复感染或持续感染,这可能是致命的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号